Category: Orthofix International
Orthofix gets a non-compliance notification from Nasdaq as the company delays its quarterly earnings report.
Orthofix (NSDQ:OFIX) said it was issued a notification from Nasdaq after not filing its quarterly report on time.
Orthofix chairman Jim Gero steps down and is replaced by private equity player Randy Thurman.
Orthofix (NSDQ:OFIX) chairman Jim Gero stepped down, effective immediately, to be replaced by Randy Thurman.
Gero, a member of the orthopedic medical device company's board since 1998, was named chairman in 2005. He'll continue as a consultant to the board until 2015, according to a press release.
A raft of shareholders sue Orthofix after the medical device company's plan to restate its financials sends share prices down 16% in a day.
Shareholders of Orthofix (NSDQ:OFIX) piled a raft of lawsuits on the medical device company, accusing it of failing to warn investors that would have to restate its financial results going back to 2011.
Orthofix delays filing its 2nd-quarter financials and says it will restate its books for the past 2 years due to improperly recognized revenues.
Orthofix (NSDQ:OFIX) said an audit of its books is prompting it to restate its financial results for 2011, 2012 and Q1 2013 after discovering revenues that were improperly recognized.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Orthofix splits its spine business into 2 units and shuffles its management deck.
Orthofix (NSDQ:OFIX) said it's splitting its global spine business into 2 segments and re-organizing its management.
A Virginia podiatrist was indicted for lying to a grand jury about her involvement in a scheme to defraud Medicare by collecting reimbursement for procedures using Orthofix's bone growth stimulator.